Connect Biopharma Holdings CNTB Cash Flow Statement (2022-2026)

NASDAQ CNTB
$0.80 -0.08 (-8.81%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Connect Biopharma Holdings Quarterly Cash Flow Statement

Periods 12 quarters
Latest Jun 2026

Connect Biopharma Holdings reported cash from operations of -$15.92M and free cash flow of -$15.92M for the quarter ended Jun 2026, down 26.5% year over year. This cash flow statement covers 12 quarters of results from Dec 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -8.69M14.85M-12.88M-8.91M-10.27M-12.90M-17.20M-15.11M-19.40M-17.28M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 0.16M0.16M0.18M0.16M0.17M0.17M0.18M0.18M0.16M0.16M
Share-based CompensationStock Comp. 1.32M1.99M2.02M1.40M0.94M0.95M0.92M0.92M1.20M1.26M
Gains from Sales and DivestituresGains Divest -0.01M0.00M-0.03M0.00M
Change in Working Capital
Change in ReceivablesChange Receivables 5.02M-4.23M-0.78M-0.01M0.02M0.00M-0.01M2.94M
Change in Account PayablesChange Payables -1.84M0.16M-0.15M-0.04M0.48M1.48M-0.30M-0.03M2.34M-2.29M
Change in Accured ExpensesChange Accured Exp. 0.73M-1.30M-0.08M-1.02M-0.56M0.70M1.00M2.23M-0.40M3.06M
Change in Other Operating AssetsOther Assets Change -1.21M3.95M-2.87M-1.66M1.30M2.23M1.81M-0.63M-0.26M-2.12M
Change in Other Operating LiabilitiesOther Liabilities Change 6.62M-19.59M0.04M-0.02M0.02M-0.47M0.00M0.00M-0.17M-0.01M
Other Working Capital ChangesOther WC Changes 7.83M-23.54M2.91M1.64M-1.28M-2.71M-1.81M0.62M0.09M2.11M
Cash from OperationsCash from Ops. -0.59M-7.70M-13.01M-2.32M-9.96M-12.59M-17.41M-11.25M-16.01M-15.92M
Investing Activities
Capital ExpendituresCapex 0.29M0.15M0.31M0.08M0.30M0.03M0.02M
Sales of Property, Plant and EquipmentPP&E (Sale) 0.00M
Change in Property, Plant and EquipmentChange in PP&E -0.29M-0.15M-0.31M-0.08M-0.30M-0.03M-0.02M
Purchase of InvestmentsInvestments Purchased 15.45M22.56M7.91M4.47M
Sale and Maturity of InvestmentsInvestments Sold 9.25M3.50M2.00M13.34M14.38M11.00M6.00M
Cash from Investing ActivitiesCash from Investing 9.25M3.21M-0.15M-15.76M-20.64M5.13M14.35M10.98M6.00M-4.47M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued 0.12M0.11M0.00M0.16M0.22M0.72M17.62M2.85M
Net Shares Issued and RepurchasedNet Shares Issued 0.12M0.11M0.00M0.16M0.22M0.72M17.62M2.85M
Net Equity Issued and RepurchasedNet Equity Issued 0.12M0.11M0.00M0.16M0.22M0.72M17.62M2.85M
Cash from Financing ActivitiesCash from Financing 0.12M0.11M0.00M0.16M0.22M0.72M17.62M1.33M
Additional items
Exchange Rate EffectFX Effect -0.22M0.10M0.51M-0.98M0.08M0.22M0.06M0.05M0.07M0.05M
Change in Cash 8.44M-4.26M-12.65M-18.96M-30.52M-7.08M-2.79M0.50M7.69M-19.02M
Ending Cash Balance 78.95M105.66M114.10M109.84M97.19M78.23M47.71M40.63M37.85M38.35M46.03M27.02M
Free Cash FlowFCF -0.59M-7.99M-13.15M-2.63M-10.04M-12.89M-17.44M-11.27M-16.01M-15.92M
Net Cash FlowNCF 8.66M-4.36M-13.15M-17.98M-30.60M-7.30M-2.85M0.45M7.62M-19.06M
Income Taxes PaidTaxes Paid 0.11M

Connect Biopharma Holdings Cash Flow Statement API

Pull Connect Biopharma Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=CNTB&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY